N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.
about
Antioxidants in Cardiovascular Therapy: Panacea or False Hope?Preliminary study of hypoxia-related cardiovascular mediator-markers in patients with end-stage renal disease with and without diabetes and the effects of haemodialysisMolecular strategies for targeting antioxidants to mitochondria: therapeutic implications.N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans.Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical ApplicationIodixanol Has a Favourable Fibrinolytic Profile Compared to Iohexol in Cardiac Patients Undergoing Elective Angiography: A Double-Blind, Randomized, Parallel Group Study.N-acetyl-cysteine exhibits potent anti-mycobacterial activity in addition to its known anti-oxidative functionsN-Acetyl-L-Cysteine inhibits the development of glucose intolerance and hepatic steatosis in diabetes-prone mice.Platelet, monocyte and neutrophil activation and glucose tolerance in South African Mixed Ancestry individuals.N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes.Glutaredoxin-2 controls cardiac mitochondrial dynamics and energetics in mice, and protects against human cardiac pathologies.Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
P2860
Q26776115-2AE12715-FF8F-4912-9734-934CAC50B240Q33719168-78D11258-AE44-4857-BB87-160AE937D2D0Q35148462-9964498E-EBA7-4394-B1C4-B8F9B164BE9EQ35232882-601D4E78-07EB-483B-B5E4-AD286756DBCAQ35806779-03154688-90D3-4853-AED4-1662214C6FC8Q35897548-4A5BB313-C04F-497C-9407-CD4267AC4CDDQ36177465-529DDDBA-7F8C-43CC-A0C4-4E941A9AF3DBQ37293137-166AA16C-E677-433C-A7B1-1AD0E417FBAFQ37587782-6B6DAD67-882D-4E29-892B-BBEADF47150DQ41927946-841AC298-280A-4F87-A4BE-9FE1D03F2E36Q45768550-71A558A9-6993-437D-BCDF-7BF1C29F703EQ50949000-36E13DB0-C294-4071-9DC6-76518628581B
P2860
N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
N-Acetylcysteine inhibits plat ...... a randomised controlled trial.
@ast
N-Acetylcysteine inhibits plat ...... a randomised controlled trial.
@en
type
label
N-Acetylcysteine inhibits plat ...... a randomised controlled trial.
@ast
N-Acetylcysteine inhibits plat ...... a randomised controlled trial.
@en
prefLabel
N-Acetylcysteine inhibits plat ...... a randomised controlled trial.
@ast
N-Acetylcysteine inhibits plat ...... a randomised controlled trial.
@en
P2093
P2860
P1433
P1476
N-Acetylcysteine inhibits plat ...... a randomised controlled trial
@en
P2093
A T Treweeke
G F Rushworth
I Mackenzie
S M MacRury
T J Winterburn
P2860
P2888
P304
P356
10.1007/S00125-012-2685-Z
P577
2012-08-31T00:00:00Z